Risk Factors for Retinal Hemorrhage after Photodynamic Therapy in Age-Related Macular Degeneration
暂无分享,去创建一个
Jaeryung Oh | K. Huh | I. Oh
[1] H. Yatsuya,et al. Seasonal variations of acute massive submacular haemorrhage associated with age-related macular degeneration , 2006, British Journal of Ophthalmology.
[2] Jennifer I. Lim,et al. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. , 2005, Archives of ophthalmology.
[3] W. Inhoffen,et al. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[4] Jennifer I. Lim,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report , 2004, Retina.
[5] N. Bressler. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. , 2003, American journal of ophthalmology.
[6] J. Jonas. VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: Meta-Analysis of 2-Year Safety Results in Three Randomized Clinical Trials: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report , 2002, American journal of ophthalmology.
[7] Simon P. Harding,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. , 2001, American journal of ophthalmology.
[8] A. M. Verbeek,et al. Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.
[9] R. Sperduto,et al. Systemic hypertension and age-related maculopathy in the Framingham Study. , 1986, Archives of ophthalmology.
[10] I. Georgalas,et al. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.
[11] Neil M Bressler,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[12] N. Bressler,et al. TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH PHOTODYNAMIC THERAPY (TAP) STUDY GROUP. PHOTODYNAMIC THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH VERTEPORFIN: TWO-YEAR RESULTS OF 2 RANDOMIZED CLINICAL TRIALS-TAP REPORT 2 , 2001 .
[13] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[14] Oates Rp,et al. Senile macular degeneration: a preliminary study. , 1982, Annals of ophthalmology.